d) at Clairo

Hanover, Lower-Saxony, Germany

Apply Now

Not SpecifiedCompensation

Internship, Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Automotive, Battery TechnologyIndustries

Requirements

Allgemeine oder fachgebundene Hochschulreife (Abitur)
Gute bis sehr gute Leistungen in Mathematik, Deutsch und Englisch sowie in betriebswirtschaftlichen und technischen Fächern
Sehr gute sprachliche Ausdrucksfähigkeit
Interesse an wirtschaftlichen Zusammenhängen
Motivation, Engagement und Eigeninitiative
Team-, Kommunikations- und Problemlösungsfähigkeit
Selbstständige Arbeitsweise
Engagierte und zielstrebige Abiturienten (m/w/d) für Start August 2026 am Standort Hannover

Responsibilities

Technische Ausbildung mit IHK-Abschluss (Mechatroniker) im 1. Studienabschnitt
Vollzeitstudium im 2. Studienabschnitt mit Theorie- und Praxisphasen
Theoriephasen an der Hochschule Hannover
Praxisphasen in den entsprechenden Abteilungen (PT - Produktionstechnik, KT - Konstruktionstechnik, WT - Wirtschaftsingenieurwesen)
Aktive Mitarbeit im Tagesgeschäft (z. B. Wartung, Reparatur, Instandhalten von Maschinen und Anlagen; Fertigung, Programmierung und Einbau von Maschinenbauteilen)
Selbständige Bearbeitung von Projekten
Abschluss mit Bachelor of Engineering (B.Eng.)
Teilnahme an Seminaren, Schulungen und spannenden Projekten

Skills

Mechatronics

Mechanical Engineering

Production Technology

Design Technology

Industrial Engineering

Machine Maintenance

Repair

Manufacturing

Programming

Installation

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free